Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Upstream Processing01:27

Upstream Processing

Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Fed-Batch Culture01:23

Fed-Batch Culture

Fed-batch culture is a widely used bioprocessing strategy combining aspects of batch culture with controlled substrate feeding to optimize cell growth and product formation. In this semi-closed system, nutrients are strategically added during fermentation, while the accumulated products and biomass remain within the bioreactor until the end of the operation. This controlled addition of substrates allows for better management of growth kinetics, nutrient limitation, and metabolite...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

CAR T cells: The next frontier.

Cytotherapy·2026
Same journal

Dialysis bioreactor enables high-density, serum-free expansion of dental pulp-derived mesenchymal stromal cells with enhanced secretome.

Cytotherapy·2026
Same journal

Beyond the synapses: should we anticipate neurotransmitter signaling when manufacturing CAR-T cells for brain tumors?

Cytotherapy·2026
Same journal

Curative treatment for severe sickle cell disease: allogeneic hematopoietic cell transplant or gene therapy.

Cytotherapy·2026
Same journal

Manufacturing strategies for prolonged CAR-T cell persistence.

Cytotherapy·2026
Same journal

Overcoming five main challenges to targeting hematologic malignancies.

Cytotherapy·2026

Related Experiment Video

Updated: Jul 5, 2026

Culturing Human Pluripotent and Neural Stem Cells in an Enclosed Cell Culture System for Basic and Preclinical Research
08:05

Culturing Human Pluripotent and Neural Stem Cells in an Enclosed Cell Culture System for Basic and Preclinical Research

Published on: June 10, 2016

Data management in the cell therapy production facility: the batch process record (BPR).

We Janssen1

  • 1H. Lee Moffitt Cancer Center, Tampa, Florida 33612, USA. william.janssen@moffitt.org

Cytotherapy
|April 18, 2008
PubMed
Summary
This summary is machine-generated.

Cell therapy manufacturing generates vast data. Adopting pharmaceutical batch process records (BPR) ensures organized data collection for regulatory compliance and best practices in cell therapy product processing.

More Related Videos

Chimeric Antigen Receptor T Cell Manufacturing on an Automated Cell Processor
06:18

Chimeric Antigen Receptor T Cell Manufacturing on an Automated Cell Processor

Published on: August 18, 2023

Large-Scale Cell Production Based on GMP-Grade Dissolvable Porous Microcarriers
09:44

Large-Scale Cell Production Based on GMP-Grade Dissolvable Porous Microcarriers

Published on: July 7, 2023

Related Experiment Videos

Last Updated: Jul 5, 2026

Culturing Human Pluripotent and Neural Stem Cells in an Enclosed Cell Culture System for Basic and Preclinical Research
08:05

Culturing Human Pluripotent and Neural Stem Cells in an Enclosed Cell Culture System for Basic and Preclinical Research

Published on: June 10, 2016

Chimeric Antigen Receptor T Cell Manufacturing on an Automated Cell Processor
06:18

Chimeric Antigen Receptor T Cell Manufacturing on an Automated Cell Processor

Published on: August 18, 2023

Large-Scale Cell Production Based on GMP-Grade Dissolvable Porous Microcarriers
09:44

Large-Scale Cell Production Based on GMP-Grade Dissolvable Porous Microcarriers

Published on: July 7, 2023

Area of Science:

  • Biotechnology
  • Pharmaceutical Sciences
  • Regulatory Science

Background:

  • Cell therapy establishments generate significant data during product processing.
  • Organized data recording and retention are crucial for best practices, regulatory compliance, and adherence to standards.
  • Cell therapy products share functional similarities with pharmaceuticals, necessitating robust data management strategies.

Purpose of the Study:

  • To propose the pharmaceutical manufacturing batch process record (BPR) as a standardized unit for collecting cell therapy processing data.
  • To review considerations for designing BPRs and selecting electronic data recording tools for cell processing facilities.
  • To address the selection, qualification, and validation of software for BPR maintenance.

Main Methods:

  • Review of existing paradigms in pharmaceutical manufacturing data management.
  • Analysis of regulatory and accreditation mandates for data collection in cell therapy.
  • Evaluation of electronic data management tools and software validation principles.

Main Results:

  • The pharmaceutical batch process record (BPR) paradigm is suitable for cell therapy data collection.
  • Key considerations for BPR design include regulatory requirements and the selection of appropriate electronic data management tools.
  • Software for BPR maintenance requires careful selection, qualification, and validation.

Conclusions:

  • Implementing a BPR system is essential for compliant and efficient cell therapy manufacturing.
  • Strategic selection and validation of electronic data management tools are critical for data integrity and regulatory adherence.
  • Standardized data recording practices enhance the quality and traceability of cell therapy products.